The DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Unilateral Ureteral Obstruction as a Model to Investigate Fibrosis-Attenuating Treatments
Open accessAbstract
Renal fibrosis is the common pathway for most forms of progressive renal disease. The Unilateral Ureteral Obstruction (UUO) model is used to cause renal fibrosis, where the primary feature of UUO is tubular injury as a result of obstructed urine flow. Furthermore, experimental UUO in rodents is believed to mimic human chronic obstructive nephropathy in an accelerated manner. Renal fibrosis is the common pathway for most forms of progressive renal disease. Removing the obstruction may not be sufficient to reverse fibrosis, so an accompanying treatment may be of benefit. In this review, we have done a revision on treatments shown to ameliorate fibrosis in the context of the UUO experimental model. The treatments inhibit the production of fibrotic and inflammatory proteins such as Transforming Growth Factor β1 (TGF-β1), Tumor Necrosis Factor α (TNF-α), collagen and fibronectin, Heat Shock Protein 47 (HSP47), suppress the proliferation of fibroblasts, prevent epithelial-to-mesenchymal transition, reduce oxidative stress, inhibit the action of the Nuclear Factor κB (NF-κB), reduce the phosphorylation of mothers against decapentaplegic homolog (SMAD) family members 2 and 3 (Smad2/3) or Mitogen-Activated Protein Kinases (MAPKs), inhibit the activation of the renin-angiotensin system. Summaries of the UUO experimental methods and alterations observed in the UUO experiments are included.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Non-Transgenic Mouse Models of Kidney Disease
Rabe, M., & Schaefer, F. (2016) · Nephron · doi:10.1159/000445171 · Cited by 1,922
Origin and function of myofibroblasts in kidney fibrosis
LeBleu, V. S., Taduri, G., O'Connell, J., Teng, Y., Cooke, V. G., Woda, C., Sugimoto, H., & Kalluri, R. (2013) · Nature Medicine · doi:10.1038/nm.3218 · Cited by 1,263
Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy
Chevalier, R. L., Forbes, M. S., & Thornhill, B. A. (2009) · Kidney International · doi:10.1038/ki.2009.86 · Cited by 1,029
Sato, M., Muragaki, Y., Saika, S., Roberts, A. B., & Ooshima, A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19270 · Cited by 831
YAP/TAZ Are Mechanoregulators of TGF-β-Smad Signaling and Renal Fibrogenesis
Szeto, S. G., Narimatsu, M., Lu, M., He, X., Sidiqi, A. M., Tolosa, M. F., Chan, L., De Freitas, K., Bialik, J. F., Majumder, S., et al. (2016) · Journal of the American Society of Nephrology · doi:10.1681/asn.2015050499 · Cited by 462
NADPH Oxidases, Reactive Oxygen Species, and the Kidney: Friend and Foe
Sedeek, M., Nasrallah, R., Touyz, R. M., & Hébert, R. L. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2012111112 · Cited by 456
The role of monocyte chemoattractant protein MCP1/CCL2 in neuroinflammatory diseases
Conductier, G., Blondeau, N., Guyon, A., Nahon, J.-L., & Rovère, C. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.05.010 · Cited by 404
Mechanisms of renal injury and progression of renal disease in congenital obstructive nephropathy
Chevalier, R. L., Thornhill, B. A., Forbes, M. S., & Kiley, S. C. (2010) · Pediatric Nephrology · doi:10.1007/s00467-009-1316-5 · Cited by 218
Unilateral ureteral obstruction: beyond obstruction
Ucero, A. C., Benito-Martin, A., Izquierdo, M. C., Sanchez-Niño, M. D., Sanz, A. B., Ramos, A. M., Berzal, S., Ruiz-Ortega, M., Egido, J., & Ortiz, A. (2014) · International Urology and Nephrology · doi:10.1007/s11255-013-0520-1 · Cited by 189
Wang, M., Chen, D., Chen, L., Cao, G., Zhao, H., Liu, D., Vaziri, N. D., Guo, Y., & Zhao, Y. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14333 · Cited by 163
Samarakoon, R., Dobberfuhl, A. D., Cooley, C., Overstreet, J. M., Patel, S. P., Goldschmeding, R., Meldrum, K. K., & Higgins, P. J. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.007 · Cited by 158
Indoxyl sulfate, a uremic toxin, downregulates renal expression of Nrf2 through activation of NF-κB
Bolati, D., Shimizu, H., Yisireyili, M., Nishijima, F., & Niwa, T. (2013) · BMC Nephrology · doi:10.1186/1471-2369-14-56 · Cited by 138
Src inhibition blocks renal interstitial fibroblast activation and ameliorates renal fibrosis
Yan, Y., Ma, L., Zhou, X., Ponnusamy, M., Tang, J., Zhuang, M. A., Tolbert, E. M., Bayliss, G., Bai, J., & Zhuang, S. (2015) · Kidney International · doi:10.1038/ki.2015.293 · Cited by 129
Recovery following relief of unilateral ureteral obstruction in the neonatal rat
Chevalier, R. L., Kim, A., Thornhill, B. A., & Wolstenholme, J. T. (1999) · Kidney International · doi:10.1046/j.1523-1755.1999.055003793.x · Cited by 124
What is the best way to measure renal fibrosis?: A pathologist’s perspective
Farris, A. B., & Alpers, C. E. (2014) · Kidney International Supplements · doi:10.1038/kisup.2014.3 · Cited by 109
Overstreet, J. M., Samarakoon, R., Meldrum, K. K., & Higgins, P. J. (2014) · Cellular Signalling · doi:10.1016/j.cellsig.2014.02.017 · Cited by 107
Wang, Y., Wang, B., Du, F., Su, X., Sun, G., Zhou, G., Bian, X., & Liu, N. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12383 · Cited by 98
The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis
Li, Y., Ma, D., Wang, Z., Hu, X.-F., Li, S.-L., Tian, H., Wang, M., Shu, Y., & Yang, J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.03.004 · Cited by 95
Recent Advances of Curcumin in the Prevention and Treatment of Renal Fibrosis
Sun, X., Liu, Y., Li, C., Wang, X., Zhu, R., Liu, C., Liu, H., Wang, L., Ma, R., Fu, M., et al. (2017) · BioMed Research International · doi:10.1155/2017/2418671 · Cited by 94
p53 induces miR199a-3p to suppress SOCS7 for STAT3 activation and renal fibrosis in UUO
Yang, R., Xu, X., Li, H., Chen, J., Xiang, X., Dong, Z., & Zhang, D. (2017) · Scientific Reports · doi:10.1038/srep43409 · Cited by 91
Blaheta, R. A., Nelson, K., Haferkamp, A., & Juengel, E. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.02.004 · Cited by 87
Deregulation of Hippo–TAZ pathway during renal injury confers a fibrotic maladaptive phenotype
Anorga, S., Overstreet, J. M., Falke, L. L., Tang, J., Goldschmeding, R., Higgins, P. J., & Samarakoon, R. (2018) · The FASEB Journal · doi:10.1096/fj.201700722r · Cited by 87
Amygdalin inhibits renal fibrosis in chronic kidney disease
Guo, J., Wu, W., Sheng, M., Yang, S., & Tan, M. J. (2013) · Molecular Medicine Reports · doi:10.3892/mmr.2013.1391 · Cited by 84
Xia, Z., Abe, K., Furusu, A., Miyazaki, M., Obata, Y., Tabata, Y., Koji, T., & Kohno, S. (2007) · American Journal of Nephrology · doi:10.1159/000108759 · Cited by 77
Abbas, N. A. T., Salem, A. E., & Awad, M. M. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1544-y · Cited by 75
Xu, W., Shao, X., Tian, L., Gu, L., Zhang, M., Wang, Q., Wu, B., Wang, X., Yao, J., Xu, X., et al. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.214205 · Cited by 74
Metformin prevents renal interstitial fibrosis in mice with unilateral ureteral obstruction
Cavaglieri, R. C., Day, R. T., Féliers, D., & Abboud, H. E. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.06.006 · Cited by 72
Zhou, X., Zhang, J., Xu, C., & Wang, W. (2014) · Journal of Pharmacological Sciences · doi:10.1254/jphs.14173fp · Cited by 66
Sun, D., Bu, L., Liu, C., Yin, Z., Zhou, X., Li, X., & Xiao, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065042 · Cited by 60
Lu, X., Zou, W., Yaqian, D., Zhou, D., Xueli, T., Dong, Z., Guanyi, L., Tang, L. Y., & Menghua, L. (2018) · Phytomedicine · doi:10.1016/j.phymed.2018.09.009 · Cited by 59
Existence of a regulatory loop between MCP-1 and TGF-β in glomerular immune injury
Wolf, G., Jocks, T., Zahner, G., Panzer, U., & Stahl, R. A. K. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00349.2001 · Cited by 54
Kim, S., Kim, S. J., Yoon, H. E., Chung, S., Choi, B. S., Park, C. W., & Shin, S. J. (2015) · International Journal of Medical Sciences · doi:10.7150/ijms.13187 · Cited by 54
Wang, W., Luo, R., Lin, Y., Wang, F., Zheng, P., Levi, M., Yang, T., & Li, C. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00649.2014 · Cited by 51
The Selective A3AR Antagonist LJ-1888 Ameliorates UUO-Induced Tubulointerstitial Fibrosis
Lee, J., Hwang, I., Lee, H., Lee, H. W., Jeong, L. S., & Ha, H. (2013) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.07.010 · Cited by 50
Nguyen, T. T., Kim, D., Lee, S., Kim, W. B., Park, S. M., & Kang, K. P. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2017.3218 · Cited by 46
Liu, M., Liu, T., Shang, P., Zhang, Y., Liu, L., Liu, T., & Sun, S. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13766 · Cited by 43
Baba, I., Egi, Y., Utsumi, H., Kakimoto, T., & Suzuki, K. T. (2015) · Molecular Medicine Reports · doi:10.3892/mmr.2015.4467 · Cited by 42
Biomarkers of obstructive nephropathy using a metabolomics approach in rat
Zhang, Z., He, J., Qin, W., Zhao, Y., & Tan, N. (2018) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.10.004 · Cited by 39
Wang, H., Qian, J., Zhao, X., Xing, C., & Sun, B. (2017) · Journal of Pharmacological Sciences · doi:10.1016/j.jphs.2016.12.005 · Cited by 38
Overstreet, J. M., Samarakoon, R., Cardona-Grau, D., Goldschmeding, R., & Higgins, P. J. (2015) · The FASEB Journal · doi:10.1096/fj.14-262527 · Cited by 35
Effects of colchicine on renal fibrosis and apoptosis in obstructed kidneys
Kim, S., Jung, E. S., Lee, J., et al. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.131 · Cited by 32
Wang, L., Chi, Y.-F., Yuan, Z., Zhou, W., Yin, P., Zhang, X., & Peng, W. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358699 · Cited by 29
Lee, W., Jao, H.-Y., Hsu, J., Lee, Y.-R., Wu, M., Kao, Y., & Lee, H. (2014) · Journal of Functional Foods · doi:10.1016/j.jff.2014.08.010 · Cited by 27
Tasanarong, A., Kongkham, S., & Khositseth, S. (2013) · BioMed Research International · doi:10.1155/2013/308130 · Cited by 24
Zheng, L., Zhang, J., Yuan, X., Tang, J., Qiu, S., Peng, Z., Yuan, Q., Xie, Y., Mei, W., Tang, Y., et al. (2017) · Nephrology · doi:10.1111/nep.13062 · Cited by 23
Park, J., Jang, K. M., An, H. J., Kim, J., Gwon, M., Gu, H., Park, B., & Park, K. (2018) · Molecules · doi:10.3390/molecules23092236 · Cited by 22
Sulfasalazine reduces inflammatory renal injury in unilateral ureteral obstruction
Demi̇rbi̇lek, S., Emre, M. H., Aydın, N. E., Edalı, M. N., Aksoy, R. T., Akın, M., Gürünlüoğlu, K., Taş, E., Ay, S., & Yılmaz, Z. (2007) · Pediatric Nephrology · doi:10.1007/s00467-006-0416-8 · Cited by 21
Fluoride potentiates tubulointerstitial nephropathy caused by unilateral ureteral obstruction
Kido, T., Tsunoda, M., Sugaya, C., Hano, H., & Yanagisawa, H. (2017) · Toxicology · doi:10.1016/j.tox.2017.10.003 · Cited by 21
Effect of curcumin on TNFR2 and TRAF2 in unilateral ureteral obstruction in rats
Hashem, R. M., Mohamed, R. H., & Abo–Elmatty, D. M. (2015) · Nutrition · doi:10.1016/j.nut.2015.10.005 · Cited by 11
Hammad, F. T., & Lubbad, L. (2011) · European Surgical Research · doi:10.1159/000324414 · Cited by 11
Metadata
- Authors
- Martínez-Klimova, E., Aparicio-Trejo, O. E., Tapia, E., & Pedraza-Chaverri, J.
- Venue
- Biomolecules
- Publisher
- MDPI AG
- Published
- 2019-04-08
- Volume
- 9
- Issue
- 4
- Pages
- 141
- ISSN
- 2218-273X (ISSN-L)
- OpenAlex
- W2927200373
- Cited by
- 319
- References
- 51
- FWCI
- 18.50
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.